Author:
Carrasco-Torres Gabriela,Fattel-Fazenda Samia,López-Alvarez Guadalupe Soledad,García-Román Rebeca,Villa-Treviño Saúl,Vásquez-Garzón Verónica Rocío
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol. 2013;10:34–42.
2. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40:667–76.
3. Wang Y, Luo Q, Li Y, Wang H, Deng S, Wei S, et al. Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer. PLoS One. 2014;9:e103939.
4. Tsai CL, Koong AC, Hsu FM, Graber M, Chen IS, Cheng JC. Biomarker studies on radiotherapy to hepatocellular carcinoma. Oncology. 2013;84 Suppl 1:64–8.
5. Malagari K, Pomoni M, Sotirchos VS, Moschouris H, Bouma E, Charokopakis A, et al. Long term recurrence analysis post drug eluting bead (deb) chemoembolization for hepatocellular carcinoma (hcc). Hepato-Gastroenterology. 2013;60:1413–9.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献